These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9210602)

  • 21. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells.
    Matsuura Y; Suzuki T; Suzuki R; Sato M; Aizaki H; Saito I; Miyamura T
    Virology; 1994 Nov; 205(1):141-50. PubMed ID: 7975209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and methodological evaluation of a chemiluminescence assay for detection of anti-envelope protein (E1, E2) antibodies in the serum of hepatitis C virus-infected patients.
    Wang N; Liu Q; Che F; Sun Q; Wang Y; Yang C; Dai Y; Cheng J
    J Clin Lab Anal; 2024 Feb; 38(4):e25011. PubMed ID: 38491776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis.
    Psichogiou M; Katsoulidou A; Vaindirli E; Francis B; Lee SR; Hatzakis A
    Transfusion; 1997 Aug; 37(8):858-62. PubMed ID: 9280333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
    Zhao W; Liao GY; Jiang YJ; Jiang SD
    Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.
    Liu J; Zhu LX; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2005 Jan; 11(4):503-7. PubMed ID: 15641134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
    Ralston R; Thudium K; Berger K; Kuo C; Gervase B; Hall J; Selby M; Kuo G; Houghton M; Choo QL
    J Virol; 1993 Nov; 67(11):6753-61. PubMed ID: 8411378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prokaryotic expression of hepatitis C virus envelope 1 gene and application of the expressed product].
    Gao J; Tao Q; Ma D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):20-3. PubMed ID: 12526296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
    Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
    J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and immunological evaluation of the Escherichia coli-derived hepatitis C virus envelope E1 protein.
    Lorenzo LJ; García O; Acosta-Rivero N; Dueñas-Carrera S; Martínez G; Alvarez-Obregón J; Pichardo D; Ramos A; Guerra I; Morales J
    Biotechnol Appl Biochem; 2000 Oct; 32(2):137-43. PubMed ID: 11001874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of glycoprotein hepatitis C virus in mammalian cell and application of purified protein for detection of antibody against E2 in hepatitis C patients].
    Zhu C; Wu C; Tao Q
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):214-6. PubMed ID: 10715790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
    Zaaijer HL; Vallari DS; Cunningham M; Lesniewski R; Reesink HW; van der Poel CL; Lelie PN
    J Med Virol; 1994 Dec; 44(4):395-7. PubMed ID: 7534821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
    Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
    J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977.
    Grellier L; Brown D; Power J; Dusheiko G
    J Viral Hepat; 1997; 4(6):379-81. PubMed ID: 9430357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological evaluation of Escherichia coli-derived hepatitis C virus second envelope protein (E2) variants.
    Dueñas-Carrera S; Viña A; Garay HE; Reyes O; Alvarez-Lajonchere L; Guerra I; González LJ; Morales J
    J Pept Res; 2001 Sep; 58(3):221-8. PubMed ID: 11576328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.
    Zhao W; Liao GY; Jiang YJ; Jiang SD
    World J Gastroenterol; 2003 Oct; 9(10):2226-31. PubMed ID: 14562383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation.
    Gane EJ; Maertens G; Ducatteeuw A; Qian KP; Lau JY; Jones H; Davies E; Naoumov NV; Williams R
    Transplantation; 1999 Jan; 67(1):78-84. PubMed ID: 9921800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.